Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)

  • Product Code
  • ILEA003441960
  • Registered date
  • 2024/10/13 00:00:00
  • Credit
  • NurPhoto / Kyodo News Images
  • Media source
  • Artur Widak/NurPhoto
  • Media size
  • 4000 × 2667 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 5.20(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

    BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
      Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

      Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

      BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
        Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

        Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

        BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)